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Abstract
Delta-like 1homolog (Dlk1) is an imprinted gene encoding a transmembrane protein whose increased expression has been
associated with muscle hypertrophy in animal models. However, the mechanisms by which Dlk1 regulates skeletal muscle
plasticity remain unknown. Here we combine conditional gene knockout and over-expression analyses to investigate the
role of Dlk1 in mouse muscle development, regeneration and myogenic stem cells (satellite cells). Genetic ablation of Dlk1 in
the myogenic lineage resulted in reduced body weight and skeletal muscle mass due to reductions in myofiber numbers
and myosin heavy chain IIB gene expression. In addition, muscle-specific Dlk1 ablation led to postnatal growth retardation
and impaired muscle regeneration, associated with augmented myogenic inhibitory signaling mediated by NF-kB and
inflammatory cytokines. To examine the role of Dlk1 in satellite cells, we analyzed the proliferation, self-renewal and
differentiation of satellite cells cultured on their native host myofibers. We showed that ablation of Dlk1 inhibits the
expression of the myogenic regulatory transcription factor MyoD, and facilitated the self-renewal of activated satellite cells.
Conversely, Dlk1 over-expression inhibited the proliferation and enhanced differentiation of cultured myoblasts. As Dlk1 is
expressed at low levels in satellite cells but its expression rapidly increases upon myogenic differentiation in vitro and in
regenerating muscles in vivo, our results suggest a model in which Dlk1 expressed by nascent or regenerating myofibers
non-cell autonomously promotes the differentiation of their neighbor satellite cells and therefore leads to muscle
hypertrophy.
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Introduction
The paternally expressed Delta-like 1 homolog (Dlk1) gene (Entrez
Gene ID 13386) lies within the imprinted Dlk1 – Dio3 gene cluster
on distal mouse chromosome 12 and encodes a transmembrane
epidermal growth factor (EGF)-like protein[1]. The extracellular
domain of Dlk1 can also be cleaved to generate a soluble form,
called fetal antigen 1, which circulates as an abundant growth
factor during development [2]. Another splice variant lacks the
proteolytic cleavage site and remains constitutively membrane
bound (Dlk1-C2). This membrane-bound form is most common in
postnatal skeletal muscle [3,4]. Like many imprinted genes, Dlk1 is
an important regulator of mammalian development and its
expression level has dramatic effects on cellular proliferation and
differentiation. Elevated Dlk1 expression is associated with many
tumors including acute myeloid leukemia [5,6,7,8,9,10]. Accumu-
lating evidence further indicates that Dlk1 is an important
regulator of not only proliferation and differentiation of embryonic
and adult stem cells but also functions to maintain the
pluripotency of embryonic stem cells [4,11,12,13,14,15,16].
Recent reports indicate that Dlk1 may play important roles in
skeletal muscle development. Transcript and protein levels of Dlk1
are highest in developing fetal muscle and taper off quickly after
birth [2,17]. Interestingly, increased numbers of Dlk1
+ mononu-
clear cells and myofibers are reported in several myopathies
including Becker and Duchenne muscular dystrophies which
involves active muscle degeneration and regeneration [17]. Studies
using transgenic mice over expressing Dlk1 [3,18] and callipyge
mutation in sheep causing increased expression of Dlk1
[3,19,20,21] have also indicated that high levels of Dlk1 increase
skeletal muscle mass in neonates. Callipyge sheep exhibit a
significant increase in the size and proportion of type IIB fibers in
muscles of the hind-quarters [22,23,24,25]. Muscle-specific over-
expression of Dlk1 in mice yields similar results with an increase in
total muscle mass and fiber diameter by six weeks of age [3].
Important roles of Dlk1 in muscle development is also evident by
the observations that Dlk1-null mice show distinct phenotypes
including increased mortality during late gestation and early
neonatal development, skeletal malformations, and decreased
growth rates accompanied by increased adiposity [26]. However,
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membrane bound versus cleaved forms in muscle development
and growth is unclear; 2) as Dlk1 can be cleaved and circulate, it is
unknown whether muscle specific Dlk1 expression is necessary for
normal muscle development and growth; 3) what role does Dlk1
play in postnatal muscle regeneration and muscle progenitor cells?
In addition, the mechanisms by which Dlk1 regulates skeletal
muscle development and hypotrophy are poorly understood. Due
to the EGF-like domain in Dlk1, it is classified into the same family
as the Notch receptors and ligands including Delta and Serrate
(Jagged) [10,27]. Unlike Delta and Serrate, however, Dlk1 lacks
the DSL (delta/serrate/lag) domain known to be essential for
activation of Notch receptors. Therefore, Dlk1 is thought to
interact with the Notch receptors through its EGF repeats as an
antagonist and down-regulate signaling through Notch in
Drosophila and Notch-1 in mammalian cell cultures [28,29,30].
Activation and suppression of Notch receptors by Delta occur in
both cis (Delta suppresses Notch on the same cell; cell autonomous)
or trans (Delta from one cell activates Notch on a neighboring cell;
non-cell autonomous) manner [31]. Such distinction in signaling
among progenitor cells would fit in the model of asymmetric
cellular commitment seen in activated satellite cells in muscle [32].
Activated Notch signaling inhibits the formation of muscle
progenitor cells in Drosophila [33,34,35] and delays the expression
and activation of MyoD and myogenin, markers of muscle
differentiation, in mammals [36,37]. This suggests a model in
which Dlk1 facilitates muscle differentiation through dampening
of Notch signaling. However, a recent study suggests that Dlk1
does not interact with Notch1 receptor nor requires Notch
activation to exert its effect on preadipocyte differentiation[38].
Satellite cells are muscle-specific stem cells that lie quiescent
beneath the basal lamina of adult myofibers until needed for
muscle repair. Following an injury, satellite cells proliferate and
incorporate their nuclei into existing fibers while still maintaining
their stem cell population. Donor satellite cells have even been
shown to engraft onto recipient fibers to repair injured myofibers
and ameliorate disease progression [32,39,40,41,42]. The status of
a satellite cell, whether self-renewing, proliferating, or differenti-
ating, can be determined by the expression of Pax7 and MyoD
[43,44,45,46,47,48,49,50,51,52]. We use these markers to deter-
mine the molecular mechanisms by which Dlk1 regulates fate of
satellite cells during muscle development/regeneration.
To investigate the requirement of muscle specific Dlk1 in
myogenic development and postnatal muscle repair, we generated
a conditional Dlk1 knock-out mouse using a Dlk1-floxed allele
together with a Myf5-Cre driver. Since Myf5 is the earliest
expressed myogenic regulatory factor in developing embryos and
is required for myogenic determination [53,54], this model is
useful to determine how Dlk1 function in both myogenic
progenitor cells and mature skeletal muscles. Our results show
that muscle-specific depletion of Dlk1 leads to defective muscle
development, elevated inflammatory responses, and delayed
muscle regeneration. We further provide evidence that Dlk1
non-cell autonomously affects satellite cell fate choice between self-
renewal and differentiation.
Results
Defective muscle formation, growth retardation, and
altered myosin heavy chain gene expression in muscle-
specific Dlk1 mutant mice
The role of membrane-bound Dlk1 in skeletal muscle was
investigated by creating a conditional mutant mouse model. We
used the Myf5-Cre mouse to inactivate Dlk1 in the myogenic
lineage [53,54] of Dlk1
flox mice. As Dlk1 is an imprinted gene
expressed only from paternal allele [1], paternal heterozygous
Myf5-Cre/Dlk1
+(m)/flox(p) displayed identical Dlk1 expression
profiles and phenotypes as the homozygous Myf5-Cre/Dlk1
flox/
flox alleles (data not shown). Thus, Dlk1
flox/+ males were crossed
with Myf5-Cre females to produce paternal heterozygotes for
muscle-specific Dlk1 knockout (henceforth Dlk1 cKO).
By performing qPCR assays we found ,35% reduction in Dlk1
expression in whole muscles of Dlk1 cKO, suggesting that Dlk1
expressed by myofibers only accounts for about one-third of the
total Dlk1 mRNA expressed by the whole muscle (Fig. 1A). These
results are in agreement with our immunohistological results that
Dlk1 is mainly expressed by interstitial non-myogenic cells within
the muscle (Supplementary Fig. S1). To confirm muscle-specific
knockout of Dlk1, we isolated single myofibers from EDL muscles
and quantified Dlk1 expression, which was reduced by ,90% in
the Dlk1 cKO myofibers (Fig. 1A). The residual (10%) Dlk1
expression detected in isolated Dlk1 cKO myofibers probably
originated from contaminating interstitial cells attached on the
fibers[44]. Furthermore, Dlk1 levels in Dlk1 cKO brown adipose
tissue (BAT) were reduced by 80%, again in agreement with our
recent report that the brown adipose tissue is derived from a Myf5-
lineage[55]. In contrast, white adipose tissue, known to be derived
from Myf5-independent lineages[55], exhibited no changes in
Dlk1 expression. These results confirm specific deletion of Dlk1 in
muscle and brown fat lineage mediated by the Myf5-Cre allele.
The Dlk1 cKO mice were born at expected Mendelian ratios
(Expected ratio: 25%; observed ratio 25.963.9%, n=17 litters)
and appeared to be healthy and behaviorally normal. However,
notable phenotypic differences were observed in the Dlk1 cKO
mice compared to wild-type siblings. First, the mutants displayed a
significant reduction in body weight (Fig. 1B); this reduction
appeared to be more prominent at older age (11% reduction in old
vs 5% in young mice, however p=0.34). The brown fat mass also
decreased by 20% in the Dlk1 cKO mice (Fig. 1C). To further
determine if the observed body weight loss was mainly due to
reduced muscle mass, we compared the number of muscle fibers in
representative fast (EDL, Fig. 1D) and slow (soleus, Fig. 1H)
muscles. Indeed, there is a roughly 25% reduction in total
myofiber numbers in the cKO in both muscle types (Fig. 1E & I),
which likely contributes to the 5–10% decrease in body mass, as
skeletal muscles generally account for about 40% of total body
weight. As myofiber numbers are known to be fixed at birth[56],
the reduced number of myofibers in cKO reflects defects in
embryonic myogenic development. Together, these observations
suggest that our Dlk1conditional mutation leads to defective
muscle development and postnatal growth retardation.
Over-expression of DLK1 in Callipyge sheep muscle is linked to
a switch in fiber type towards fast twitch glycolytic fibers that
express the myosin heavy chain (MyHC) IIB gene. We therefore
examined if the deletion of Dlk1 leads to fiber type switching. A
marked reduction in mRNA levels of MyHC IIB was detected in
the Dlk1 cKO mice in both EDL and SOL muscles (Fig. 1F & J),
whereas the expression of other MyHC genes were not affected (not
shown). MyHC isoform-specific monoclonal antibody labeling of
EDL and SOL muscles, however, did not indicate any differences
in the proportion of each fiber type (Fig. 1G & K). Therefore,
muscle-specific ablation of Dlk1 appears to reduce the levels of fast
type IIB MyHC, but does not lead to fiber type switching in mice.
Delayed muscle regeneration in Dlk1 cKO
To investigate how Dlk1 deficiency may affect adult myogen-
esis, The tibialis anterior (TA) muscles of Dlk1 cKO and wild-type
mice were given intramuscular injections of CTX and the
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Regeneration of the TA muscle was considerably impaired in the
Dlk1 cKO at 5–7 days after injury, a time point at which
regeneration peaked in the wild-type mice. Skeletal muscle
regeneration involves the repair of existing degenerated fibers
and de novo formation of new fibers. Existing fibers undergoing
active repair can be readily identified by their large diameter with
centrally localized nuclei and non-specific IgG binding due to
immune cell infiltration (Fig 2A). De novo formed new fibers are
considerably smaller in diameter with central nuclei. While wild-
type muscles regenerated uniformly with little fibrosis and
scarification (Fig. 2A–C), the Dlk1 cKO muscles were poorly
regenerated with extensive fibrosis, scarification, and interstitial
space occupied by massive cellular infiltration (Fig. 2D–F).
The defective regeneration of Dlk1 cKO fibers is substantiated
by a significant decrease in myogenin mRNA expression levels
(Fig. 2G) and a roughly 25% decrease in nascent de novo fiber
formation (Fig. 2H) five days after injury. In addition, phosphor-
ylated Akt (the activated form) levels were decreased in the cKO
(Fig. 2I), suggesting an impairment of the Akt/mTOR signaling
pathway that is known to promote protein synthesis and myotube
hypertrophy [57]. This observation is consistent with our previous
finding that Akt signaling is enhanced in DLK1 over-expressing
callipyge sheep [58]. Together, these data suggest that Dlk1 is
necessary for proper skeletal muscle regeneration in adult mice.
Elevated inflammatory response to injury in Dlk1 cKO
muscles
As muscle injury causes an inflammatory immune response
within the damaged tissue [59],we examined whether aberrant
inflammatory responses contributed to the defective regeneration
of the Dlk1 cKO muscles. The increased interstitial nuclei density
in regenerating cKO muscles (Fig. 2F) indicates excessive
infiltrated macrophages, which was confirmed by the high mRNA
levels of CD68 (Fig. 3C), a cell surface marker for macrophages.
Nuclear factor kappa B (NF-kB) is a major pro-inflammatory
transcription factor controlling the expression of a plethora of
genes involved in inflammation and immune responses [60].
Several published reports have suggested that NF-kB inhibits
myogenesis at multiple levels including suppression of MyoD
[61,62]. Moreover, it has been found that muscle-specific
inhibition of NF-kB dramatically improves skeletal muscle
Figure 1. Myf5-Cre mediated mutation of paternal Dlk1(cKO) results in defects in muscle formation and growth. Asterisks in all graphs
denote p,0.05compared to wild-type (WT) controls. A: Quantitative PCR confirming muscle-specific Dlk1 knockout in cKO mice in whole muscle,
myofibers, myoblasts and BAT. B: Relative body weight (BW) of WT (n=17, 9, 4 for all age, 2–4 month and 10–12 month mice, respectively) and cKO
(n=18, 9, 5) littermates. C: Relative mass of BAT of WT (n=3) and cKO (n=3) mice. D–K: Muscle fiber composition in representative fast-twitch (EDL)
and slow-twitch soleus (SOL) muscles revealed by MyHC isoform-specific antibodies and qPCR. D: MyHC isoform staining of representative EDL. Total
myofiber number for EDL(E) and SOL (I) muscle in WT and cKO (n=4 pairs). Myosin heavy chain (MyHC) IIB gene expression in EDL (F) and SOL (J;n=3
pairs) muscles. Percent of each MyHC isoform by immunostaining in EDL (G) and SOL (K; n=3 pairs).
doi:10.1371/journal.pone.0015055.g001
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therefore sought to investigate whether depletion of Dlk1 affects
the activation of NF-kB transcription factor in regenerating
muscles. DNA-binding activity of NF-kB in regenerating muscle
was found to be markedly higher in Dlk1 cKO mice compared to
wild-type mice (Fig. 3A). The increased activation of NF-kB
pathway was also evident by our results that the levels of
phosphorylated IkBa was up-regulated in regenerating muscle of
Dlk1cKO mice compared to those of wild-type mice (Fig. 3B).
Furthermore, the expression of NF-kB-regulated pro-inflammato-
ry cytokines IL-1b and TNF-a was also significantly higher in
myofibers of Dlk1cKO mice compared to wild-type mice in
response to injury (Fig. 3D–E). Both TNF-a and IL-1b have been
previously shown to inhibit myogenesis [62,63,64]. Collectively,
these data suggest that the loss of Dlk1 exacerbates the
inflammatory response and augments the expression of inflam-
matory cytokines which may be responsible for the reduced
myofiber regeneration after injury.
Dlk1 ablation leads to reduced MyoD expression and
facilitates self-renewal of activated satellite cells
The defective muscle regeneration suggests that our muscle-
specific Dlk1 mutation may also affect the normal function of
satellite cells, which underlies muscle regeneration. To investigate
this possibility, the potential effects of Dlk1 on satellite cell self-
renewal and differentiation were assessed ex vivo by activating
quiescent satellite cells attached to single EDL myofibers in culture.
In this model, satellite cells initially only express Pax7, then activate
MyoD, and enter the cell cycle. Proliferating cells then either down-
regulate Pax7 in order to differentiate, or down-regulate MyoD and
self-renew[43,45,51]. After 3 days in culture, distinctive clusters of
myoblasts are readily detectable on myofibers. Myoblast clusters
were stained for Pax7 and MyoD so that Pax7
+/MyoD
2,P a x 7
+/
MyoD
+, and Pax7
2/MyoD
+ cells represent self-renewing, prolifer-
ating, and differentiating cells, respectively (Fig. 4A–H).
The average number of cells per cluster was not significantly
different between wild-type and conditional mutants (Fig. 4I). In
Figure 2. Muscle-specific Dlk1 cKO results in impaired muscle regeneration after injury. A–F: Morphology of TA muscle 1 week after
cardiotoxin injury in WT (A–C) and cKO mice (D–F). A, D: Fluorescent immunostaining of mouse IgG showing injured fibers in red and Dapi nuclei
staining in green. B, E: Brightfield images showing increased fibrosis and scarification (Dark signal due to poor light penetration) in cKO mutant
muscles. C, F: H–E staining showing poor organization and increased infiltration of non-myogenic cells in mutant muscles. G: Myogenin mRNA levels
increase after injury, but cKO mice have an impaired myogenin response (n=4). H: Total number of nascent fibers (n=7 pairs) are decreased in cKO
injured muscles. I: Levels of phosphorylated Akt are decreased in cKO muscle compared to WT control and injured muscles.
doi:10.1371/journal.pone.0015055.g002
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in the cKO compared with the wildtype cells (Fig. 4J). However, a
significant reduction of cells expressing MyoD was observed in the
cKO cells (Fig. 4J), leading to a shift in the cell fate status.
Specifically, the proportion of self-renewing cells (Pax7
+/MyoD
2)
was increased in the Dlk1 cKO while proliferating cells (Pax7
+/
MyoD
+) were decreased (Fig. 4K). These results suggest that the
lack of Dlk1-initiated signaling promotes satellite cell fate choice
towards the self-renewal state as the expense of proliferation.
Over-expression of Dlk1 promotes myoblast cell cycle
withdrawal and differentiation
To directly test how Dlk1 regulates myoblasts, we over-
expressed the membrane-bound form of Dlk1 in C2C12 and
primary myoblasts using the Neon transfection system (Invitrogen,
Inc.), which gives 50–75% transfection efficiency in our hands. We
first over-expressed Dlk1 in C2C12 myoblasts (Fig. 5A–B).
Strikingly, C2C12 cells over-expressing Dlk1 failed to expand
and the cell number at day 3 after transfection was only 30% that
of the GFP (N1-GFP, Clontech) transfected control (Fig. 5C). To
confirm that Dlk1 is indeed over-expressed, we measured the
mRNA and protein levels of Dlk1 in control and Dlk1 transfected
cells. Dlk1-transfected C2C12 cells expressed 230 times more
mRNA and much higher protein levels of Dlk1 compared to
control cells transfected with GFP (Fig. 5D–E). Similar reductions
in cell numbers were observed in satellite cell-derived primary
myoblasts over-expressing Dlk1 (Data not shown). To investigate if
the observed reduction in cell number is due to an inhibition of cell
proliferation, we co-transfected primary myoblasts with 4:1 ratio of
Dlk1 and GFP plasmids and measured cell proliferation with Ki67,
a well-established cell proliferation marker (Fig. 5F). Notably, Ki67
expression was found to be rarely co-localized to the GFP
+ cells
(Fig. 5F), which should also be positively transfected with Dlk1 due
to the much higher (4x) concentrations of Dlk1 plasmids used
during transfection. Quantification showed that the percentages of
Ki67
+ cells in GFP
+ cells was only 17.5%, compared to 46.2% in
GFP
2 cells (Fig. 5G). To further confirm this observation, we
examined Ki67 expression in primary myoblasts electroporated
with empty plasmid (Fig. 5H) or Dlk1 plasmid (Fig. 5I). We found
that the average intensity of Ki67 immunofluorescene (normalized
to DAPI fluorescence) is significantly reduced in the Dlk1 over-
expressing cells (Fig. 5J). These results demonstrate that Dlk1 over-
expression inhibits myoblast proliferation.
Strikingly, primary myoblasts over-expressing Dlk1 displayed
accelerated differentiation kinetics. At confluent cell density, it
typically takes 4 days before primary myoblasts are fully
differentiated. At 2 days after induced differentiation by serum
withdrawal, only few myotubes were detectable in the control cells
(Fig. 5K), whereas Dlk1 over-expressing cells readily differentiate
and numerous myotubes were detectable at the same time point
(Fig. 5L). Additionally, the average size of the myotubes formed
was significantly larger in the Dlk1 over-expressing cells (Fig. 5M),
Figure 3. Muscle-specific Dlk1 cKO results in increased inflammation and NF-kB signaling after injury. A–B: NF-kB pathway is up-
regulated in cKO injured muscle as indicated by increase DNA binding by nuclear NF-kB( A) and phosphorylated Ik-Ba (B). C: CD68 (macrophage
marker) mRNA levels are increased in cKO injured muscles (n=4). D–E: Pro-inflammatory cytokines IL-1b (D) and TNF-a (E) are up-regulated in cKO
injured muscles (n=4).
doi:10.1371/journal.pone.0015055.g003
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MF20 immunofluorescence, is roughly 2.5 times higher in the Dlk1
over-expressing cells (Data not shown). These observations provide
direct evidence that Dlk1 promotes myogenic differentiation.
As extracellular ligands such as Dlk1 commonly exerts their
effects on neighbor cells in a cell-contact dependent manner, we
hypothesized that Dlk1 over-expression non-cell autonomously
regulates myoblast proliferation and differentiation. To confirm
that the observed effect of Dlk1 on myoblast differentiation is non-
cell autonomous, we examined myoblast growth and differentia-
tion in the presence of Dlk1 coated substrate. Wild-type myoblasts
were allowed to proliferate and differentiate on a bed of Matrigel
(BD Biosciences) containing vehicle control (Fig. 5N) or 500 ng/ml
of recombinant Dlk1 protein (Fig. 5O). Cells differentiated in the
presence of recombinant Dlk1 had reduced Ki67 expression (Data
not shown) but formed significantly larger myotubes than cells
grown under control conditions (Fig. 5P). These data, combined
with the loss-of-function analysis, provide strong evidence that
high levels of exogenous Dlk1 promote cell cycle withdrawal and
differentiation of myoblasts into myotubes.
Dlk1 upregulation correlates to myoblast differentiation
and muscle regeneration in vivo
Our data establish a non-cell autonomous role of Dlk1 in
myogenic differentiation. To determine the physiological rele-
vance of this observation, we examined whether Dlk1 upregulation
correlates to myoblast differentiation. Indeed, Dlk1 protein
expression, along with myosin heavy chain protein expression, is
upregulated in newly differentiated myotubes 5 days after
induction of differentiation (Fig. 6A). In addition, both mRNA
(Fig. 6B) and protein (Fig. 6C) levels of Dlk1 were significantly
upregulated 5 days after CTX-induced muscle regeneration in
vivo. In contrast, Dlk1 protein levels were very low in both
quiescent and activated satellite cells, but elevated in newly
regenerated myofibers (Supplementary Fig. S1A&C). Similarly,
cultured myoblasts expressed much lower levels of Dlk1 mRNA in
relative to isolated myofibers or whole muscles (Supplementary
Fig. S1D). Combined with our earlier results from Dlk1 cKO,
these results indicate that Dlk1 upregulation is correlated and
necessary for normal differentiation of muscle progenitor cells.
Based on our findings and previous observations, we propose a
model in which the timing of Dlk1 critically affect muscle
regeneration after injury (Fig. 6D). Upon muscle injury, satellite
cells are activated and proliferate. Dlk1 level in the whole muscle
peaks at the height of satellite cell proliferation (Fig. 6A–C),
allowing many of the proliferating myoblasts to differentiate and
repair the muscle damage. As Dlk1 levels later drop[17], a portion
of undifferentiated cells then return to the self-renewed state, or
quiescence. The level of Dlk1 available on neighboring tissues
during satellite cell activation determines, in a non-cell autono-
Figure 4. Dlk1 regulates satellite cell self-renewal and differentiation. A–D: Pax7 and MyoD expression in a representative cluster of
myoblasts on a wild-type EDL fiber after 3 days of culture. Pax7
+/MyoD
2, Pax7
+/MyoD
+ and Pax7
2/MyoD
+ cells represent self-renewing, proliferating
and differentiating cells, respectively. E–H: A representative cluster of myoblasts on a cKO fiber cultured under identical culture conditions. I: The
average number of cells per cluster. J: The percentage of cells expressing Pax7 and MyoD (note that most cells co-express Pax7 and MyoD; see K
below). K: The proportion of cells at three different statuses: self-renewal (S–R; Pax7
+/MyoD
2), differentiation (Diff; Pax7
2/MyoD
+) and proliferation
(Prolif; Pax7
+/MyoD
+). In I–K, n=34 for WT, and n=27 for cKO; * indicates p,0.05 compared to WT.
doi:10.1371/journal.pone.0015055.g004
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PLoS ONE | www.plosone.org 6 November 2010 | Volume 5 | Issue 11 | e15055Figure 5. Dlk1 over-expression (OE) or recombinant Dlk1 protein inhibits proliferation but promotes differentiation of myoblasts.
A–B: Dlk1 over-expression in C2C12 myoblasts. Cells were transfected with either GFP (Control; A)o rDlk1 OE (B) plasmids and cultured for 3 days.
C: Cell numbers of Control and Dlk1 OE at day 3 after transfection. D–E: Relative Dlk1 mRNA levels in the Control and Dlk1 OE cells measured by
quantitative Realtime PCR (n=4). E: Protein levels of Dlk1, GFP and a-tubulin in GFP control transfected cells (GFP), Dlk1 over-expression cells
(DLK1), and cells transfected with an unrelated negative control gene (TSG101). F: Primary myoblasts co-transfected with Dlk1 and GFP (4:1)
plasmids were cultured for 2 days and labeled with a cell proliferation marker Ki67 together with GFP staining. GFP signals (indicating Dlk1 positively
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of Dlk1 promote higher rates of differentiation while low levels
trigger more self-renewing cells. However, our model does not
exclude a potential cell-autonomous role of Dlk1 in myoblast
differentiation. Finally, our Dlk1cKO mice had significantly higher
levels of NF-kB activation, pro-inflammatory cytokines, and
macrophage infiltration. Thus endogenous Dlk1 may also be
required to limit the inflammatory response in regenerating
muscles.
Discussion
Delta-like 1 (Dlk1) exists in both a cleaved circulating form and
a constitutively membrane bound form and is crucial for the
proper development of several tissues in mammals. However, the
specific functions and signaling mechanisms of the predominantly
membrane-bound form (Dlk1-C2) in skeletal muscle and muscle
progenitor cells remain unclear. Previous reports have indicated
that muscle-specific over-expression of Dlk1 causes postnatal
muscle hypertrophy in both mice and sheep [20,21,65,66].
However, the phenotype in sheep is complicated as the callipyge
mutation also alters the expression of several other imprinted
genes near the Dlk1 allele [19,20,21,66,67,68,69,70]. In addition,
constitutive Dlk1 knockouts and over-expression are mostly
embryonic or perinatal lethal[18,26,71]. This study was thus
designed to elucidate the role of local non-circulating Dlk1 in
skeletal muscle development and regeneration by creating a
muscle-specific Dlk1 knock-out mouse (Dlk1 cKO). Floxed Dlk1
mice were crossed with a Cre driver allele under the control of the
Myf5 promoter. Myf5 is an early critical muscle regulatory
factor[32], so Dlk1-flox/Myf5-Cre mice have their Dlk1 gene
excised during early embryonic development of muscle progenitor
cells.
By measuring the expression levels of Dlk1 in muscle-specific
knock-out mice, it was observed that Dlk1 levels were only
decreased by 35% in whole muscle compared to wild-type siblings.
However, when Dlk1 was measured on isolated myofibers and
myoblasts, the levels were greatly decreased in muscle-specific
mutants, similar to data from Dlk1-null mice. Further investigation
showed the Dlk1 protein is still detectable in mutant whole muscles
originating from non-myogenic cells, mostly endothelial CD31
+
cells. This is consistent with a recent study that reports many
Dlk1
+ cells found in adult muscle are mesenchymal or fibroblastic
in nature, rather than myogenic [17]. However, our data do not
indicate that Dlk1 is normally present in satellite cells, contrary to
findings by Andersen and others [17]. Our findings suggest that
Dlk1 from neighboring interstitial cells or myofibers [2,4] interacts
with satellite cells to influence their physiological state.
The total number of muscle fibers was significantly reduced in
our conditional mutant mice. This may account for decreased total
body mass that is observed when comparing Dlk1 cKO mice to
wild-type littermates. This phenotype was not expected since the
over-expression of Dlk1 does not change the number of myofibers
present, only their size and metabolic functions [25]. One
possibility is that by removing Dlk1 early in myogenic progenitor
cells, the formation of primary and/or secondary myotubes in the
embryo may be compromised.
Because of fiber type changes observed in Dlk1 over-expression
models, myosin heavy chain isoforms were measured by qPCR
and immuohistochemistry in our Dlk1 cKO mutants. The mRNA
levels of myosin heavy chain type IIB were significantly reduced in both
the soleus and EDL muscles of mutant mice, while no other
isoforms appeared to change. This is consistent with Dlk1over-
expression models where the expression of type IIB myosin heavy
chain was found to be increased in both sheep and mice
[22,25,65]. This suggests that Dlk1 may play a role in either
contraction speed or energy metabolism in the muscle.
The role of Dlk1 in muscle regeneration was observed by
challenging muscles with a cardiotoxin (CTX) injury. We found
that muscle regeneration was impaired at several levels in the Dlk1
cKO mice. Myogenin levels and the number of nascent de novo
Figure 6. Dlk1 up-regulation correlates to myogenic differen-
tiation and skeletal muscle regeneration after injury. A:
Representative Western-blot image showing that Dlk1 protein levels
increase 5 days after serum-withdrawal induced differentiation of
C2C12 myoblasts. B: The relative level of Dlk1 mRNA in the TA muscle
revealed by quantitative Realtime PCR 5 days after cardiotoxin-induced
regeneration (* indicates P,0.05; n=18 for control TA; 6 for CTX treated
TA). C: Dlk1 protein expression revealed by Western-blot in resting and
regenerating TA muscles 5 days after cardiotoxin treatment. D: A model
depicting how Dlk1 level varies during muscle quiescence and
regeneration, which correlates to suppression of NK-kB activity and
the onset of myoblast differentiation.
doi:10.1371/journal.pone.0015055.g006
transfected cells) exhibit little colocalized with Ki67 immunofluorescence. G: Percentage of cells displaying Ki67 staining in Control and Dlk1 OE
cells (n=3). H–J: Primary myoblasts transfected with an empty plasmid (H, control) or Dlk1 plasmid (I, OE) cultured for 3 days in growth medium and
labeled with Ki67 (in red) and DAPI (in blue). The average Ki67 immunofluorescenc intensity was measured with Photoshop and normalized to DAPI
intensity (J, n=3 per treatment). K–M: Phase-contrast images of primary myoblasts differentiated for 48 hrs after transfected with either empty
plasmids (K) or Dlk1 OE plasmids (L). M: Average pixel size of myotubes in Control and Dlk1 OE treatments as shown in H&I (n=20 random tubes
measured). N–O: Primary myoblasts grown on Matrigel plus vehicle control (N) and on Matrigel plus Dlk1 recombinant protein (O) after 3 days in
differentiation medium. Green fluorescence (MF20) marks sarcomere myosin heavy chain and Blue is DAPI counterstaining for nuclei. P: The
relative diameters of the resulting myotubes as shown in N&Owere measured with Image J software. Control is the open bar (n=66 myotubes) and
Dlk1 recombinant protein treated cells are represented by the solid black bar (n=66 myotubes). Asterisks in all bar graphs indicate p,0.05 compared
to control groups by student t-test.
doi:10.1371/journal.pone.0015055.g005
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of pro-inflammatory cytokines were greatly increased. Increased
levels of TNF-a have been shown to decrease nascent myofiber
genesis [72,73] which along with IL-1b, activate the NF-kB
signaling pathway [62,74,75]. We observed high levels of NF-kB
in mutant regenerating muscle of Dlk1 cKO mice. Several studies
have shown that NF-kB tightly controls myogenesis and
specifically inhibits myofiber formation both in vitro and in vivo
[61,76]. Our data show that lack of Dlk1 in skeletal muscle
increases inflammatory response after injury and impairs regen-
eration potentially through increased activation of NF-kB and
expression of inflammatory cytokines. It is also possible that the
enhanced inflammatory reaction to muscle injury is due to the
poor regeneration of the Dlk1 cKO muscle. Furthermore, reduced
phosphorylation of Akt in regenerating myofibers of Dlk1
2cKO
mice suggests that Dlk1 may be enhancing myofiber regeneration
though the activation of this kinase. Alternatively, inhibition in Akt
phosphorylation could be a result of less myofiber regeneration in
Dlk1 cKO mice.
We provide direct evidence that Dlk1 function to regulate
myogenic progenitor cells. Mice possessing the conditional Dlk1
mutation showed higher proportions of self-renewing cells at the
expense of fewer proliferating cells (Fig. 4). In opposition, myoblast
differentiation is accompanied by higher levels of Dlk1 protein
(Fig. 6). More importantly, overexpression of Dlk1 inhibited
myoblast proliferation and promoted their differentiation (Fig. 5).
These results support a role of Dlk1 in the regulation of the
proliferation and differentiation of satellite cells and provide a
mechanism by which Dlk1 overexpression leads to muscle
hypertrophy as seen in callipyge sheep and transgenic mice
[3,18,19].
It remains unknown what signals regulates Dlk1 expression in
regenerating and nascent myofibers, and the Dlk1 downstream
effectors that affect myoblast proliferation and differentiation. Our
results are consistent with the notion that Dlk1 acts as an inhibitor
for Notch signaling [28,29,30]. Notch signaling is known to inhibit
MyoD expression and myogenic differentiation, but enhance
satellite cell proliferation and self-renewal[77,78]. Based on this
notion, our Dlk1 conditional mutants should have elevated Notch
signaling, which would suppress MyoD expression[79]. Our results
confirmed this prediction. Conversely, over-expression of Dlk1
should suppress Notch signaling and promote myogenic differen-
tiation, but inhibit myoblast proliferation[80,81]. Our overexpres-
sion studies again support this notion. Interestingly, recent studies
have also shown that Notch signaling interacts with the canonical
NF-kB pathway. Notch-1 is able to promote the transcription of
TNF-a [82,83], which in turn stimulates the phosphorylation of
IkBa, leading to the activation of NF-kB signaling [83]. Notch-1 is
also known to affect macrophage and cultured B cell signaling.
Wild-type macrophages increase Notch-1 expression after an
immune challenge, which then promotes the transcription of pro-
inflammatory cytokines such as TNF-a [82]. In Notch-1-null mice,
the immune response and NF-kB activity were three times lower
in B-cells compared to wild-type cells [84].Thus, the increased
immune response seen in our Dlk1 cKO injured mice is likely the
result of increased Notch-1 signaling, which again support the
notion that Dlk1 acts to suppress Notch signaling.
In summary, our data provide novel insight into the
mechanisms of action of Dlk1 in skeletal muscle. First we show
that ablation of Dlk1 in the Myf5-derived myogenic cells leads to
both developmental and postnatal growth/regeneration defects in
myogenesis. As the conditional mutants should have normal levels
of circulating Dlk1 which is mainly produced by the fetal liver, our
results suggest that muscle specific membrane-bound Dlk1 is
important for normal myogenesis. We next show that lack of Dlk1
in injured muscle increases the inflammatory response, increasing
NF-kB signaling, and decreasing Akt activity. These shifts greatly
decrease the ability of the injured muscle to regenerate
appropriately. We further show that at progenitor cell level,
Dlk1 expression inhibits myoblast proliferation but promotes
myogenic differentiation. Therefore, the observed up-regulation of
Dlk1 in wild-type muscles after injury may act to allow
proliferating myoblasts to differentiate and fuse with existing
fibers for muscle repair. When Dlk1 is not present in neighboring
tissues, myoblasts are shifted towards the self-renewal state while
increasing the inflammatory response, thus hindering muscle
repair. These results add to our current understanding of the
cellular and molecular mechanisms by which Dlk1 regulates
skeletal muscle hypertrophy.
Materials and Methods
Mice and Animal Care
Generation of Dlk1-floxed mice will be described elsewhere
(Appelbe et al., in preparation). Briefly, loxP cassettes were
inserted into the endogenous Dlk1 locus flanking exons four and
five, and the mice were maintained in a C57BL/6 background.
Myf5-Cre mice [85] were provided by Dr. Philip Soriano (Mount
Sinai School of Medicine, New York, NY). Mice maintenance and
experimental use were performed according to protocols approved
by the Purdue Animal Care and Use Committee (PACUC
protocol # 08-006).
Muscle Injury and Regeneration
Muscle regeneration studies were performed using cardiotoxin
(CTX; Sigma-Aldrich, St. Louis, MO, USA) injections into the TA
muscle. Mice were anesthetized using a ketamine-xylazine
cocktail, then 25 mLo f1 0mM CTX was injected into the right
TA muscle. Muscles were then harvested either at 5 days post-
injection for peak regeneration activity or 2–3 weeks post-injection
to assess the completion of regeneration and repair.
Whole Muscle Sections and Staining
Whole muscles (TA, EDL, and soleus) were dissected and either
frozen immediately in OCT compound or fixed. For fixation,
muscles were placed in 4% PFA for 1 h, 100 mM glycine for h,
then 30% sucrose overnight at 4uC. Fixed samples were then
frozen in OCT compound. Frozen muscles were cut into 10 mm
thick cross sections by a Leica CM1850 cryostat. Immunohisto-
chemistry staining of muscle sections were performed as previously
described[44]. Specific primary antibodies can be found in
Supplemental Table S1. Fluorescent images were captured with
a Coolsnap HQ CCD camera (Photometrics, USA) driven by IP
Lab software (Scanalytics Inc, USA) using a Leica DM6000
microscope with a 20X objective (NA=0.70). H–E staining
images were captured by a Nikon D90 digital camera installed on
a Nikon (Diaphot) inverted microscope. Monochrome images
were processed and composited into color images using Photoshop
(CS3) software.
Single Fiber Culture and Staining
Single myofibers were isolated from the EDL muscles by
collagenase I (Roche Applied Science) digestion and tituration as
previously described [86,87]. Suspended fibers were cultured on
60 mm horse serum-coated plates in DMEM media supplemented
with 10% fetal bovine serum, 0.5% chick embryo extract, and 1%
penicillin-streptomycin for three days. Fibers were then fixed in
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GFP, as previously described[44].
Primary Myoblast Isolation and Culture
Primary myoblasts were isolated from hind limb skeletal muscle.
Muscles were minced and digested in type I collagenase and
dispase B mixture (Roche Applied Science). Cells were then
filtered from debri, centrifuged, and cultured in growth media (F-
10 Ham’s medium supplemented with 20% fetal bovine serum,
4 ng/mL basic fibroblast growth factor, and 1% penicillin-
streptomycin) on collagen-coated dishes at 37uC, 5% CO2.
Differentiation media consisted of DMEM supplemented with
5% horse serum, 1% penicillin-streptomycin
Myoblast cultures testing the presence of recombinant Dlk1
protein were maintained on a bed of 1 mg/mL BD Matrigel
(Basement Membrane Matrix; BD Biosciences, San Jose, CA,
USA). Experimental cultures also contained 500 ng/mL of
recombinant Dlk1 protein (Dlk1(mouse): Fc(human), cat#ALX-
201-416-C010; Alexis Biochemicals-Enzo Life Sciences Interna-
tional, Inc. Plymouth Meeting, PA, USA) in the Matrigel bed.
Cells were maintained in the same culture media conditions as
listed above for proliferation and differentiation.
Transfection of C2C12 Cells and primary myoblasts
C2C12 cells and primary myoblasts were transfected using the
Neon
TM Transfection System (Invitrogen, Inc) according to the
manufacturer’s recommended protocol. Dlk1 or GFP-containing
plasmids were transfected at a rate of 2 mg of plasmid DNA in
2610
5 cells. C2C12 cells were then plated in 6-well plates and
grown in DMEM with 10% FBS, 1% penicillin/streptomycin.
Primary myoblasts were grown under identical conditions as
described above in the Primary myoblast isolation and culture section.
RNA Isolation and Quantitative PCR Analysis
Tissue samples for RNA were excised after euthanization and
either stored in RNAlater (Ambion, Woodlands, TX) for later
processing or homogenized immediately for RNA purification
using the Qiagen RNeasy Fibrous Tissue Mini Kit (Qiagen, Inc.,
Valencia, CA). The on-column DNase treatment included in the
kit was used to remove any trace amounts of genomic DNA.
Purified RNA samples were then quantified by fluorometry
(Quant-iT Ribogreen RNA Quantitation Kit, Invitrogen-Molec-
ular Probes, Eugene, OR). Equal amounts of RNA were reverse
transcribed using random hexamer primers and M-MLV reverse
transcriptase (Invitrogen, Inc., Carlsbad, CA).
Quantitative PCR was performed using the Roche Lightcycler
480 system with Roche SYBR Green Master Mix reagents (Roche
Applied Science, Indianapolis, IN). Samples were assayed in
duplicate with 80 ng of cDNA per 10 uL reaction. Ribosomal protein
large protein 38 (Rplp38) was used as the housekeeping gene for all
gene expression studies. Primer sequences and PCR conditions are
listed in Supplemental Table S2. Fold expression values relative to
the wild-type samples within each tissue were calculated using the
2
2DDCT method. Statistical significance was determined by
ANOVA using the MIXED procedure of SAS (SAS Institute
Inc., Cary, NC, USA).
Western Blots and Electrophoretic Mobility Shift Assay
(EMSA)
Levels of different proteins in skeletal muscle were determined
by performing Western immunoblotting as described [88,89].
Briefly, tissues were washed with phosphate-buffered saline (PBS)
and homogenized in western blot lysis buffer (50 mM Tris-Cl
[pH 8.0], 200 mM NaCl, 50 mM NaF, 1 mM dithiotheritol
(DTT), 1 mM sodium orthovanadate, 0.3% IGEPAL, and
protease inhibitors). Approximately 100 mg of protein were
resolved on each lane on 10–12% SDS-PAGE, electrotransferred
onto nitrocellulose membrane, and probed with specific antibodies
(Supplemental Table S1) and detected by chemiluminescence.
The bands were quantified using ImageQuant TL software (GE
Healthcare).
NF-kB activation in skeletal muscle was analyzed by EMSA as
previously described [88] with some modifications. In brief, TA
muscles isolated from mice were immediately frozen in liquid
nitrogen and suspended at 1 mg muscle weight per 18 ml of low
salt lysis buffer (10 mM HEPES [pH 7.9], 10 mM KCl, 1.5 mM
MgCl2, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM dithiothreitol,
0.5 mM phenylmethylsulfonyl fluoride, 2.0 mg/ml leupeptin,
2.0 mg/ml aprotinin, 0.5 mg/ml benzamidine) followed by
mechanical grinding using mortar and pastle. Cells in the lysis
buffer were allowed to swell on ice for 10 min followed
immediately by three cycles of freeze-thaw lysis. The tubes
containing the lysed muscle cells were then vortexed vigorously for
10 s, and the lysate was centrifuged for 30 s at 14,000 rpm. The
supernatant (cytoplasmic extracts) was removed and saved at
270uC for further biochemical analysis. The nuclear pellet was
resuspended in 4 ml of ice-cold high-salt nuclear extraction buffer
(20 mM HEPES [pH 7.9], 420 mM NaCl, 1 mM EDTA, 1 mM
EGTA, 150 mM MgCl2, 25% glycerol, 1 mM dithiothreitol,
0.5 mM phenylmethylsulfonyl fluoride, 2.0 mg/ml leupeptin,
2.0 mg/ml aprotinin, 0.5 mg/ml benzamidine) per mg of original
muscle weight and was incubated on ice for 30 min with
intermittent vortexing. Samples were centrifuged for 5 min at
4uC, and the supernatant (nuclear extract) was either used
immediately or stored at 270uC. The protein content was
measured by the method of BioRad (Hercules, CA) protein assay
reagent. EMSAs were performed by incubating 20 mg of nuclear
extract with 16 fmol of the
32P-end-labeled NF-kB consensus
oligonucleotide 59-AGT TGA GGG GAC TTT CCC AGG C-39
(Promega, Madison, WI) for 15 min at 37uC. The incubation
mixture included 2–3 mg of poly dI.dC in a binding buffer (25 mM
HEPES [pH 7.9], 0.5 mM EDTA, 0.5 mM dithiothreitol, 1%
Nonidet P-40, 5% glycerol, 50 mM NaCl). The DNA-protein
complex thus formed was separated from free oligonucleotide on
7.5% native polyacrylamide gel, using buffer containing 50 mM
Tris, 200 mM glycine (pH 8.5), and 1 mM EDTA. The gel was
dried, and the radioactive bands were visualized and quantitated
by a PhosphorImager (GE Healthcare), using ImageQuant
software.
Supporting Information
Figure S1 Localization and expression of Dlk1 in
skeletal muscles. A: Lack of Dlk1 expression in quiescent
Pax7+ satellite cells in a cross section of a resting muscle. B: Co-
localization of Dlk1 with interstitial CD31
+ endothelial lineage
cells. C: Up-regulation of Dlk1 expression in newly regenerated
myofibers (small caliber fibers with central nuclei) but not in Pax7+
satellite cells in a regenerating muscle 5 days after cardiotoxin
treatment. D: Relative Dlk1 mRNA expression in whole muscles,
single myofibers isolated from EDL muscle and cultured myoblasts
(n = 18, 4, 2 respectively; * indicates significant difference
compared to whole muscle).
(TIF)
Table S1 List of antibodies used in this study.
(DOC)
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